5 Stocks Under $5 with Huge Upside Potential

3. MannKind Corporation (NASDAQ:MNKD)

MannKind Corporation (NASDAQ:MNKD) is one of the best stocks under $5 with huge upside potential. Mizuho cut the price target on MannKind Corporation (NASDAQ:MNKD) to $8 from $10 on April 13 and reaffirmed an Outperform rating on the shares. The firm adjusted price targets and estimates for a number of stocks under its coverage in the medical devices and diagnostics group ahead of its fiscal Q1 earnings.

MannKind Corporation (NASDAQ:MNKD) also received a rating update from Truist on April 8. The firm cut the price target on the stock to $6 from $7, reiterating a Buy rating on the shares. The rating update came as part of a broader research note previewing fiscal Q1 earnings in Biotech, with the firm telling investors in the research note that reactivity to regulatory and policy shifts across the sector is continuing to ease. Truist also stated that it is seeing a recent pickup in deal activity, which holds the potential to build momentum through the remainder of the year into midterms.

The firm sees a robust catalyst path for MannKind Corporation (NASDAQ:MNKD), which could spark momentum for shares, with peds Afrezza label expansion PDUFA set for May 29, 2026, Furoscix ReadyFlow autoinjector PDUFA on July 26, and developmental updates for MNKD-201 in IPF – Part 1 of the phase 1b INFLO study expected to be completed this month.

MannKind Corporation (NASDAQ:MNKD) is a biopharmaceutical company that develops and commercializes innovative therapeutic devices and products that address serious unmet medical needs for endocrine and orphan lung diseases. The company’s pipeline and products include Afrezza, Pediatric Afrezza, V-Go, Tyvaso DPI, MNKD-101, MNKD-201, MNKD-301, and MNKD-501.